Irritable Bowel Syndrome News and Research

Latest Irritable Bowel Syndrome News and Research

Keryx Biopharmaceuticals' perifosine receives FDA Fast Track Designation

Keryx Biopharmaceuticals' perifosine receives FDA Fast Track Designation

Side effects may limit use of Prometheus's Lotronex for IBS

Side effects may limit use of Prometheus's Lotronex for IBS

Juventas Therapeutics commences enrollment in Phase I trial of JVS-100 for treatment of Class III heart failure

Juventas Therapeutics commences enrollment in Phase I trial of JVS-100 for treatment of Class III heart failure

Gastrointestinal tract disorders GERD and IBS interlinked

Gastrointestinal tract disorders GERD and IBS interlinked

2010 DDW conference to highlight breakthrough research on GI health

2010 DDW conference to highlight breakthrough research on GI health

Mayo Clinic introduces a reliable and easy-to-understand resource on alternative medicine

Mayo Clinic introduces a reliable and easy-to-understand resource on alternative medicine

Vidazorb probiotic supplements could minimize severity of IBS symptoms

Vidazorb probiotic supplements could minimize severity of IBS symptoms

Renowned expert to present latest research on gut microbes at EICC

Renowned expert to present latest research on gut microbes at EICC

Colorectal cancer survivor shares her experience

Colorectal cancer survivor shares her experience

Lexicon Pharmaceuticals completes public offering and concurrent private placement of common stock

Lexicon Pharmaceuticals completes public offering and concurrent private placement of common stock

Synergy Pharmaceuticals commences dosing in Phase IIa clinical trial of SP-304 in CC patients

Synergy Pharmaceuticals commences dosing in Phase IIa clinical trial of SP-304 in CC patients

Working rotating shifts may increase risk of developing IBS and abdominal pain

Working rotating shifts may increase risk of developing IBS and abdominal pain

Hypnotherapy and probiotics effective for reducing IBS symptoms

Hypnotherapy and probiotics effective for reducing IBS symptoms

Lexicon Pharmaceuticals announces pricing of public offering and concurrent private placement of common stock

Lexicon Pharmaceuticals announces pricing of public offering and concurrent private placement of common stock

IBS patients are at no greater risk of having polyps, colon cancer than healthy people undergoing colonoscopies

IBS patients are at no greater risk of having polyps, colon cancer than healthy people undergoing colonoscopies

New study suggests rising childhood obesity is linked to food allergies

New study suggests rising childhood obesity is linked to food allergies

Lexicon Pharmaceuticals proposes $95 million underwritten public offering of common stock

Lexicon Pharmaceuticals proposes $95 million underwritten public offering of common stock

Neurocrine Biosciences to sell common stock shares

Neurocrine Biosciences to sell common stock shares

Colonoscopy screening recommended for people with family history of colon cancer

Colonoscopy screening recommended for people with family history of colon cancer

NIH panel proposes multiple management strategies for lactose intolerant individuals

NIH panel proposes multiple management strategies for lactose intolerant individuals